TQ-B3101 capsules

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-B3101 capsules, covering 2020-08-18 to 2020-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor [Phase 2]